Antidiabetic preparation for oral administration
CA 2395993 A1 · Owner: Ajinomoto Co. Inc. · Inventors: Kato, Nobuo; Ninomiya, Nobutaka; Shioya, Shigeru
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Preparations comprising a sustained-release drug which is capable of lowering , the after-meal blood sugar level of diabetics to around the normal level or a , mixture of a slow-release drug, which is capable of lowering the after-meal blood sugar level to around the normal level with a quick-release drug, thereby directly lowering both of the after-meal blood sugar level and the fasting blood sugar level respectively to the normal levels by using a single preparation. It is particularly preferable that the drug capable of lowering the after-meal blood sugar level to around the normal level is nateglinide.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 27, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended December 27, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 27, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.